v.231201
Showing details for project SYSMHC00008
| SampleID |
NumReplicates |
Organism |
TissueType |
CellType |
MHCAllele |
| SampleID |
NumReplicates |
Organism |
TissueType |
CellType |
MHCAllele |
| SYSMHC00008_laumontc_160105_perreault-thibault_cada_LCL_subject3_rep3 |
5 |
Human |
|
|
HLA-A02:01,HLA-A29:02,HLA-B57:01,HLA-B44:03 |
| SYSMHC00008_laumontc_160105_perreault-thibault_cada_LCL_subject3_rep4 |
5 |
Human |
|
|
HLA-A02:01,HLA-A29:02,HLA-B57:01,HLA-B44:03 |
| SYSMHC00008_laumontc_160105_perreault-thibault_cada_LCL_subject3_rep5 |
5 |
Human |
|
|
HLA-A02:01,HLA-A29:02,HLA-B57:01,HLA-B44:03 |
| SYSMHC00008_laumontc_160105_perreault-thibault_cada_LCL_subject4_rep3 |
5 |
Human |
|
|
HLA-A01:01,HLA-A02:01,HLA-B18:01,HLA-B39:24 |
| SYSMHC00008_laumontc_160105_perreault-thibault_cada_LCL_subject4_rep4 |
5 |
Human |
|
|
HLA-A01:01,HLA-A02:01,HLA-B18:01,HLA-B39:24 |
| SYSMHC00008_laumontc_160105_perreault-thibault_cada_LCL_subject4_rep5 |
5 |
Human |
|
|
HLA-A01:01,HLA-A02:01,HLA-B18:01,HLA-B39:24 |
| SYSMHC00008_laumontc_160105_perreault-thibault_cada_LCL_subject4_rep6 |
5 |
Human |
|
|
HLA-A01:01,HLA-A02:01,HLA-B18:01,HLA-B39:24 |
Detailed view of sample SYSMHC00008_laumontc_160105_perreault-thibault_cada_LCL_subject4_rep4
| ID |
SampleID |
RawFileName |
Organism |
Process |
Tissue Type |
Cell Type |
Culture Conditions |
Disease State |
Comments |
MHCClass |
MHCAllele |
PubMed ID |
Peptide |
Isolation Method |
Antibody |
Mass Spectrometer |
LC System |
iRT Peptides |
Acquisition Mode |
Fragmentation Method |
Gradient |
Gradient Length |
Flow Rate |
Replicate Number |
| ID |
SampleID |
RawFileName |
Organism |
Process |
Tissue_Type |
Cell_Type |
Culture_Conditions |
Disease_State |
Comments |
MHCClass |
MHCAllele |
PubMed_ID |
Peptide |
Isolation_Method |
Antibody |
Mass_Spectrometer |
LC_System |
iRT_Peptides |
Acquisition_Mode |
Fragmentation_Method |
Gradient |
Gradient_Length |
Flow_Rate |
Replicate_Number |
| SYSMHC00008 |
SYSMHC00008_laumontc_160105_perreault-thibault_cada_LCL_subject4_rep4 |
SYSMHC00008_Subject4_rep4_021213_Fx100mM.raw |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
EBV transformed |
class I |
HLA-A01:01,HLA-A02:01,HLA-B18:01,HLA-B39:24 |
26728094 |
native |
Mild acid elution |
|
Orbitrap Elite |
LTQ |
no |
DDA |
CID |
3-60% |
120 |
|
1 |
| SYSMHC00008 |
SYSMHC00008_laumontc_160105_perreault-thibault_cada_LCL_subject4_rep4 |
SYSMHC00008_Subject4_rep4_021213_Fx300mM.raw |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
EBV transformed |
class I |
HLA-A01:01,HLA-A02:01,HLA-B18:01,HLA-B39:24 |
26728094 |
native |
Mild acid elution |
|
Orbitrap Elite |
LTQ |
no |
DDA |
CID |
3-60% |
120 |
|
2 |
| SYSMHC00008 |
SYSMHC00008_laumontc_160105_perreault-thibault_cada_LCL_subject4_rep4 |
SYSMHC00008_Subject4_rep4_021213_Fx50mM.raw |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
EBV transformed |
class I |
HLA-A01:01,HLA-A02:01,HLA-B18:01,HLA-B39:24 |
26728094 |
native |
Mild acid elution |
|
Orbitrap Elite |
LTQ |
no |
DDA |
CID |
3-60% |
120 |
|
3 |
| SYSMHC00008 |
SYSMHC00008_laumontc_160105_perreault-thibault_cada_LCL_subject4_rep4 |
SYSMHC00008_Subject4_rep4_021213_Fx600mM.raw |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
EBV transformed |
class I |
HLA-A01:01,HLA-A02:01,HLA-B18:01,HLA-B39:24 |
26728094 |
native |
Mild acid elution |
|
Orbitrap Elite |
LTQ |
no |
DDA |
CID |
3-60% |
120 |
|
4 |
| SYSMHC00008 |
SYSMHC00008_laumontc_160105_perreault-thibault_cada_LCL_subject4_rep4 |
SYSMHC00008_Subject4_rep4_021213_Fx75mM.raw |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
EBV transformed |
class I |
HLA-A01:01,HLA-A02:01,HLA-B18:01,HLA-B39:24 |
26728094 |
native |
Mild acid elution |
|
Orbitrap Elite |
LTQ |
no |
DDA |
CID |
3-60% |
120 |
|
5 |